6660 — AIM Vaccine Co Balance Sheet
0.000.00%
- HK$3.98bn
- HK$5.57bn
- CNY1.29bn
Annual balance sheet for AIM Vaccine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,103 | 747 | 798 | 736 | 595 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 957 | 1,091 | 1,096 | 1,080 | 1,156 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,438 | 2,359 | 2,549 | 2,483 | 2,387 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,635 | 3,020 | 3,603 | 3,604 | 3,553 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 4,688 | 8,072 | 8,876 | 7,262 | 7,314 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,131 | 1,570 | 2,250 | 2,602 | 3,090 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,266 | 3,180 | 3,916 | 3,619 | 3,949 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3,422 | 4,893 | 4,960 | 3,643 | 3,366 |
Total Liabilities & Shareholders' Equity | 4,688 | 8,072 | 8,876 | 7,262 | 7,314 |
Total Common Shares Outstanding |